Cell Therapy for Pulmonary Hypertension: What Is the True Potential of Endothelial Progenitor Cells? * Response

Circulation - United States
doi 10.1161/01.cir.0000121684.52920.0e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cell Therapy for Pulmonary Arterial Hypertension: Potential Efficacy of Endothelial Progenitor Cells and Mesenchymal Stem Cells

Advances in Pulmonary Hypertension
2012English

Is Endothelium the Origin of Endothelial Progenitor Cells?

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Endothelial Progenitor Cells in Chronic Obstructive Pulmonary Disease

OA Stem Cells
2013English

Cell Therapy for Stroke: Emphasis on Optimizing Safety and Efficacy Profile of Endothelial Progenitor Cells

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Endothelial Cells Caught in the Crosshairs of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2010English

Cathepsin L Is Required for Endothelial Progenitor Cell–induced Neovascularization

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2005English

Monoclonal Endothelial Cell Proliferation Is Present in Primary but Not Secondary Pulmonary Hypertension.

Journal of Clinical Investigation
Medicine
1998English

The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2010English

Resident Endothelial Progenitor Cells From Human Placenta Have Greater Vasculogenic Potential Than Circulating Endothelial Progenitor Cells From Umbilical Cord Blood

Cell Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy